Pre-radical prostatectomy leakage, pad use predicts post-radical prostatectomy continence
March 1st 2009Baseline urinary continence status, based on a strict definition of no leakage or pad use, is predictive of improved return of continence following radical prostatectomy, according to University of Chicago researchers.
'Gold standard' lithotripter wins clearance comparison
March 1st 2009Various aspects of shock wave lithotripsy (SWL) were the focus of several abstracts presented at the World Congress of Endourology & SWL here. Data from one U.S. group seemed to suggest, however, that SWL's "gold standard" offers better stone fragmentation and clearance than at least one newer device.
Surgeons who 'warm up' perform better during operations
February 26th 2009Surgeons who warm up for 15 to 20 minutes with simple surgical exercises before performing an operation demonstrate a substantial increase in surgical proficiency, report the authors of a study from Arizona State University, Tempe.
Researchers find new biomarker for fatal prostate cancer
February 26th 2009Researchers from Wake Forest University School of Medicine, Winston-Salem, NC, and the University of Wisconsin, Madison, have confirmed their earlier findings that men who have too much calcium in their bloodstream subsequently have an increased risk of fatal prostate cancer, but they have also identified an even more accurate biomarker: high levels of ionized serum calcium.
Contaminated erectile dysfunction drugs implicated in hypoglycemia outbreak
February 26th 2009Illegal sexual enhancement drugs tainted with the diabetes drug glyburide have been linked to an outbreak of severe hypoglycemia in more than 100 Singaporeans, according to correspondence recently published in the New England Journal of Medicine (2009; 360:734-6).
ASCO/AUA guideline: Discuss 5-alpha-reductase inhibitors to reduce prostate cancer risk
February 26th 2009Urologists and primary care physicians should discuss the use of 5-alpha-reductase inhibitors for prostate cancer prevention with men who have a PSA ?3.0 and who regularly are screened for prostate cancer and show no signs of the disease. That is the primary conclusion of a new joint guideline released by AUA and the American Society of Clinical Oncology.
Studies show promise for treating biochemical recurrence of prostate cancer
February 12th 2009The results of two new clinical studies offer hope for men who experience biochemical recurrence after primary treatment for prostate cancer. Both are scheduled for publication in the March Journal of Urology.
Testosterone replacement therapy may be viable treatment in men with prostate cancer
February 1st 2009Testosterone replacement in men with prostate cancer is a viable treatment option to improve their vitality, according to several studies presented at the Sexual Medicine Society of North America 2008 Fall Scientific Meeting.